Nuclear receptor modulation - Role of coregulators in selective estrogen receptor modulator (SERM) actions

Steroids

Volumn 90, Issue , 2014, Pages 39-43

  Feng, Qin ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coregulator; Nuclear receptor; SERM

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANIMAL; BIOLOGICAL MODEL; BREAST NEOPLASMS; FEMALE; HUMAN; POSTMENOPAUSE;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MODELS, BIOLOGICAL; POSTMENOPAUSE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 84908669367     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.06.008     Document Type: Article

References (63)

1. M.J. Tsai, and B.W. O'Malley Molecular mechanisms of action of steroid/thyroid receptor superfamily members Annu Rev Biochem 63 1994 451 486
2. S. Della Torre, V. Benedusi, R. Fontana, and A. Maggi Energy metabolism and fertility - a balance preserved for female health Nat Rev Endocrinol 10 2014 13 23
3. A. Maggi, P. Ciana, S. Belcredito, and E. Vegeto Estrogens in the nervous system: mechanisms and nonreproductive functions Annu Rev Physiol 66 2004 291 313
4. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Collaborative group on hormonal factors in breast cancer Lancet 350 1997 1047 1059
5. V. Beral Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427
6. V.C. Jordan Selective estrogen receptor modulation: a personal perspective Cancer Res 61 2001 5683 5687
7. V.C. Jordan Tamoxifen: a most unlikely pioneering medicine Nat Rev Drug Discovery 2 2003 205 213
8. S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, and H. Sasaki Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 270 1995 1491 1494
9. P. Rajbhandari, G. Finn, N.M. Solodin, K.K. Singarapu, S.C. Sahu, and J.L. Markley Regulation of estrogen receptor alpha N-terminus conformation and function by peptidyl prolyl isomerase Pin1 Mol Cell Biol 32 2012 445 457
10. A.M. Brzozowski, A.C. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, and O. Engstrom Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389 1997 753 758
11. S.A. Onate, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley Sequence and characterization of a coactivator for the steroid hormone receptor superfamily Science 270 1995 1354 1357
12. A.B. Johnson, and B.W. O'Malley Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy Mol Cell Endocrinol 348 2012 430 439
13. M.C. Louie, J.X. Zou, A. Rabinovich, and H.W. Chen ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance Mol Cell Biol 24 2004 5157 5171
14. D. Al-azawi, M.M. Ilroy, G. Kelly, A.M. Redmond, F.T. Bane, and S. Cocchiglia Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer Oncogene 27 2008 3021 3031
15. S.Y. Na, S.K. Lee, S.J. Han, H.S. Choi, S.Y. Im, and J.W. Lee Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations J Biol Chem 273 1998 10831 10834
16. J. Xu, R.C. Wu, and B.W. O'Malley Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family Nat Rev Cancer 9 2009 615 630
17. D.M. Heery, E. Kalkhoven, S. Hoare, and M.G. Parker A signature motif in transcriptional co-activators mediates binding to nuclear receptors Nature 387 1997 733 736
18. A.K. Shiau, D. Barstad, P.M. Loria, L. Cheng, P.J. Kushner, and D.A. Agard The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 95 1998 927 937
19. H. Chen, R.J. Lin, R.L. Schiltz, D. Chakravarti, A. Nash, and L. Nagy Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 Cell 90 1997 569 580
20. D. Chen, H. Ma, H. Hong, S.S. Koh, S.M. Huang, and B.T. Schurter Regulation of transcription by a protein methyltransferase Science 284 1999 2174 2177
21. J.J. Voegel, M.J. Heine, M. Tini, V. Vivat, P. Chambon, and H. Gronemeyer The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways EMBO J 17 1998 507 519
22. T.E. Spencer, G. Jenster, M.M. Burcin, C.D. Allis, J. Zhou, and C.A. Mizzen Steroid receptor coactivator-1 is a histone acetyltransferase Nature 389 1997 194 198
23. W. Zwart, V. Theodorou, M. Kok, S. Canisius, S. Linn, and J.S. Carroll Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer EMBO J 30 2011 4764 4776
24. S. Karmakar, E.A. Foster, and C.L. Smith Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity Endocrinology 150 2009 1588 1596
25. A. Malovannaya, R.B. Lanz, S.Y. Jung, Y. Bulynko, N.T. Le, and D.W. Chan Analysis of the human endogenous coregulator complexome Cell 145 2011 787 799
26. C.E. Foulds, Q. Feng, C. Ding, S. Bailey, T.L. Hunsaker, and A. Malovannaya Proteomic analysis of coregulators bound to ERalpha on DNA and nucleosomes reveals coregulator dynamics Mol Cell 51 2013 185 199
27. J. Xu, Y. Qiu, F.J. DeMayo, S.Y. Tsai, M.J. Tsai, and B.W. O'Malley Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene Science 279 1998 1922 1925
28. A. Mukherjee, S.M. Soyal, R. Fernandez-Valdivia, M. Gehin, P. Chambon, and F.J. Demayo Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse Mol Cell Biol 26 2006 6571 6583
29. J. Xu, L. Liao, G. Ning, H. Yoshida-Komiya, C. Deng, and B.W. O'Malley The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development Proc Natl Acad Sci USA 97 2000 6379 6384
30. S.L. Anzick, J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, and X.Y. Guan AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer Science 277 1997 965 968
31. M.I. Torres-Arzayus, J. Font de Mora, J. Yuan, F. Vazquez, R. Bronson, and M. Rue High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene Cancer Cell 6 2004 263 274
32. J.D. Chen, and R.M. Evans A transcriptional co-repressor that interacts with nuclear hormone receptors Nature 377 1995 454 457
33. A.J. Horlein, A.M. Naar, T. Heinzel, J. Torchia, B. Gloss, and R. Kurokawa Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor Nature 377 1995 397 404
34. X. Hu, and M.A. Lazar The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors Nature 402 1999 93 96
35. V. Perissi, L.M. Staszewski, E.M. McInerney, R. Kurokawa, A. Krones, and D.W. Rose Molecular determinants of nuclear receptor-corepressor interaction Genes Dev 13 1999 3198 3208
36. L. Nagy, H.Y. Kao, J.D. Love, C. Li, E. Banayo, and J.T. Gooch Mechanism of corepressor binding and release from nuclear hormone receptors Genes Dev 13 1999 3209 3216
37. M.G. Guenther, W.S. Lane, W. Fischle, E. Verdin, M.A. Lazar, and R. Shiekhattar A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness Genes Dev 14 2000 1048 1057
38. L. Nagy, H.Y. Kao, D. Chakravarti, R.J. Lin, C.A. Hassig, and D.E. Ayer Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase Cell 89 1997 373 380
39. Y.D. Wen, V. Perissi, L.M. Staszewski, W.M. Yang, A. Krones, and C.K. Glass The histone deacetylase-3 complex contains nuclear receptor corepressors Proc Natl Acad Sci USA 97 2000 7202 7207
40. C.L. Smith, Z. Nawaz, and B.W. O'Malley Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen Mol Endocrinol 11 1997 657 666
41. T.A. Jackson, J.K. Richer, D.L. Bain, G.S. Takimoto, L. Tung, and K.B. Horwitz The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT Mol Endocrinol 11 1997 693 705
42. P. Webb, P. Nguyen, and P.J. Kushner Differential SERM effects on corepressor binding dictate ERalpha activity in vivo J Biol Chem 278 2003 6912 6920
43. Y. Yamamoto, O. Wada, M. Suzawa, Y. Yogiashi, T. Yano, and S. Kato The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes J Biol Chem 276 2001 42684 42691
44. S. Jiang, R. Meyer, K. Kang, C.K. Osborne, J. Wong, and S. Oesterreich Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor Mol Endocrinol 20 2006 311 320
45. T.A. Nguyen, D. Hoivik, J.E. Lee, and S. Safe Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex Arch Biochem Biophys 367 1999 250 257
46. Y. Shang, and M. Brown Molecular determinants for the tissue specificity of SERMs Science 295 2002 2465 2468
47. D.J. Scott, A.T. Parkes, F. Ponchel, M. Cummings, I. Poola, and V. Speirs Changes in expression of steroid receptors, their downstream target genes and their associated co-regulators during the sequential acquisition of tamoxifen resistance in vitro Int J Oncol 31 2007 557 565
48. C.K. Osborne, V. Bardou, T.A. Hopp, G.C. Chamness, S.G. Hilsenbeck, and S.A. Fuqua Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer J Natl Cancer Inst 95 2003 353 361
49. J. Shou, S. Massarweh, C.K. Osborne, A.E. Wakeling, S. Ali, and H. Weiss Mechanisms of tamoxifen resistance. increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer J Natl Cancer Inst 96 2004 926 935
50. Q. Su, S. Hu, H. Gao, R. Ma, Q. Yang, and Z. Pan Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells Oncology 75 2008 159 168
51. W. Zwart, A. Griekspoor, V. Berno, K. Lakeman, K. Jalink, and M. Mancini PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1 EMBO J 26 2007 3534 3544
52. E.K. Keeton, and M. Brown Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT Mol Endocrinol 19 2005 1543 1554
53. R.M. Lavinsky, K. Jepsen, T. Heinzel, J. Torchia, T.M. Mullen, and R. Schiff Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes Proc Natl Acad Sci USA 95 1998 2920 2925
54. I. Girault, F. Lerebours, S. Amarir, S. Tozlu, M. Tubiana-Hulin, and R. Lidereau Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen Clin Cancer Res 9 2003 1259 1266
55. A. Romano, M. Adriaens, S. Kuenen, B. Delvoux, G. Dunselman, and C. Evelo Identification of novel ER-alpha target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen Mol Cell Endocrinol 314 2010 90 100
56. A. Hurtado, K.A. Holmes, T.R. Geistlinger, I.R. Hutcheson, R.I. Nicholson, and M. Brown Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen Nature 456 2008 663 666
57. A. Daverey, R. Saxena, S. Tewari, S.K. Goel, and A. Dwivedi Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene J Steroid Biochem Mol Biol 116 2009 93 101
58. D. Kressler, M.B. Hock, and A. Kralli Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen J Biol Chem 282 2007 26897 26907
59. D.M. Lonard, S.Y. Tsai, and B.W. O'Malley Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins Mol Cell Biol 24 2004 14 24
60. Haugan Moi LL, Hauglid Flageng M, Gandini S, Guerrieri-Gonzaga A, Bonanni B, Lazzeroni M, et al. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue. Clin Cancer Res 2010;16:2176-2186.
61. Dieli-Conwright CM, Spektor TM, Rice JC, Todd Schroeder E. Oestradiol and SERM treatments influence oestrogen receptor coregulator gene expression in human skeletal muscle cells. Acta Physiol (Oxf) 2009;197:187-196.
62. R.C. Wu, J. Qin, P. Yi, J. Wong, S.Y. Tsai, and M.J. Tsai Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways Mol Cell 15 2004 937 949
63. P. Yi, R.C. Wu, J. Sandquist, J. Wong, S.Y. Tsai, and M.J. Tsai Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1) Mol Cell Biol 25 2005 9687 9699